Mutational Spectrum of T-Cell Large Granular Lymphocytic Leukemia: Insights From the AACR Project GENIE Consortium
Cancer Genomics - Proteomics · 2026
DOI: 10.21873/cgp.20566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2026. Verfasst von Bhanu Surabi Upadhyayula und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of California, Davis, CA, U.S.A. Hauptthemen laut MEDLINE: Leukemia, Large Granular Lymphocytic, Mutation, Biomarkers, Tumor. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: T-cell large granular lymphocyte leukemia (T-LGLL) is a rare, indolent lymphoproliferative disorder of cytotoxic T cells in the peripheral blood, bone marrow, and spleen. This analysis was conducted to characterize genomic alterations and highlight potential therapeutic targets, with the goal of refining the molecular landscape of T-LGLL by emphasizing population-specific biomarkers. MATERIALS AND METHODS: This study utilized the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) database to identify common gene mutations. Using the AACR GENIE database, a retrospective analysis of T-cell large granular lymphocyte leukemia (T-LGLL) samples was performed. The data was evaluated by extracting patient demographics and excluding synonymous mutations from consideration. Statistical significance was assessed using chi-squared tests and computational analyses in RStudio (R Foundation for Statistical Computing, Boston, MA, USA). Somatic mutations and chromosomal copy number variations were evaluated, with statistical significance defined as p=0.001. RESULTS: Frequently observed somatic mutations included STAT3 (41.7%), STAT2 (20.9%), KMT2D (11.3%), SETD1B (8.7%), TP53 (7.0%), TNFAIP3 (6.1%), DNMT3A (5.2%), FAS (4.3%), SMARCA4 (3.5%), EPHB1 (2.6%), KSR2 (2.6%), ALOX12B (2.6%), EGFR (2.6%), DDX3X (7.0%), and IKZF3 (1.7%). When stratified by demographic variables, males and White patients demonstrated a higher frequency of mutations. CONCLUSION: This study provides a comprehensive genomic profile of T-LGLL, identifying recurrent somatic mutations and commonly affected pathways. Notably, frequent alterations were observed in the FAS-FASL signaling pathway, underscoring its potential as a target for therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, University of California, Davis, CA, U.S.A.
- School of Medicine, Creighton University, Phoenix, AZ, U.S.A.
- School of Life Sciences, Arizona State University, Tempe, AZ, U.S.A.
- School of Medicine, Creighton University, Omaha, NE, U.S.A.
- School of Medicine, Creighton University, Omaha, NE, U.S.A. abubakartauseef@creighton.edu.
Zitieren
APA
Upadhyayula, B. S., Saglimbeni, G. S., Gobel, E., Gobel, A., Morris, T. J., Surendra, A., Hsia, B., Sood, A., & Tauseef, A. (2026). Mutational Spectrum of T-Cell Large Granular Lymphocytic Leukemia: Insights From the AACR Project GENIE Consortium. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20566
Vancouver
Upadhyayula BS, Saglimbeni GS, Gobel E, Gobel A, Morris TJ, Surendra A, et al. Mutational Spectrum of T-Cell Large Granular Lymphocytic Leukemia: Insights From the AACR Project GENIE Consortium. Cancer Genomics - Proteomics. 2026. doi:10.21873/cgp.20566
BibTeX
@article{Upadhyayula2026,
author = {Upadhyayula, Bhanu Surabi and Saglimbeni, Grace S and Gobel, Edie and Gobel, Abbi and Morris, Tyson J and Surendra, Akaash and Hsia, Beau and Sood, Akshat and Tauseef, Abubakar},
title = {Mutational Spectrum of T-Cell Large Granular Lymphocytic Leukemia: Insights From the AACR Project GENIE Consortium},
journal = {Cancer Genomics - Proteomics},
year = {2026},
doi = {10.21873/cgp.20566}
}
EUVIMED